Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012;12 Suppl 1(Suppl 1):S23.
doi: 10.1186/1471-2482-12-S1-S23. Epub 2012 Nov 15.

Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily

Affiliations
Randomized Controlled Trial

Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily

Fabrizio Iacono et al. BMC Surg. 2012.

Abstract

Background: Reduced libido is widely considered the most prominent symptomatic reflection of low testosterone (T) levels in men. Testosterone deficiency (TD) afflicts approximately 30% of men aged 40-79 years. This study seeks to evaluate the effect of a new natural compound "tradamixina "in order to improve male sexual function in elderly men, particularly libido and possible erectile dysfunction, versus administration of tadalafil 5 mg daily.

Methods: Seventy patients (67.3 ± 3.7 years) with stable marital relations and affected by reduced libido, with or without erectile dysfunction were recruited. They were randomly separated in 2 groups A-B of 35. Group A was administered twice a day a new compound "Tradamixina" (150 mg of Alga Ecklonia Bicyclis, 396 mg of Tribulus Terrestris and 144 mg of D-Glucosamine and N-Acetyl-D-Glucosamine) for two months, while Group B was administered tadalafil 5 mg daily, for two months. At visit and after 60 days of treatment patients were evaluated by means of detailed medical and sexual history, clinical examination, laboratory investigations (Total and Free T), instrumental examination (NPTR- nocturnal penile tumescence and rigidity test- with Rigiscan). Patients completed a self-administered IIEF questionnaire (The international index of erectile function) and SQoLM questionnaire (Sexual quality of life Questionnarie-Male). The results pre and post treatment were compared by Student t test (p<0.005).

Results: After 2 months of treatment in group A serum TT levels (230 ± 18 ng/dl vs 671 ± 14 ng/dl ) and FT levels(56 ± 2.4 pg/ml vs 120 ± 3.9 pg/ml) increased, while in group B serum TT levels (245 ± 12 ng/dl vs 247 ± 15 ng/dl ) and FT levels(53 ± 0.3 pg/ml vs 55 ± 0.5 pg/ml) increased not statistically significant. The patient's numbers with negative NPTR improved after treatment in group A and B (15 vs 18 and 13 vs 25 respectively). The IIEF total score in group A increased after treatment with tradamixina (15 ± 1.5 vs 29.77 ± 1.2); the IIEF total score in group B increased slightly (12 ± 1.3 vs 23.40 ± 1.2). The SQoLM total score improved in both groups (A:16 ± 2,3 vs 33 ± 4,1 and B: 16 ± 3,4 vs 31 ± 2,1).

Conclusion: The treatment twice a day with "Tradamixina" for 2 months improved libido in elderly men without side effects of Tadalafil.

PubMed Disclaimer

Figures

Fig1
Fig1
Serum Total Testosterone Level Pre and Post Treatment with Tadalafil 5mg daily.
Fig.2
Fig.2
Serum Total Testosterone Level Pre and Post Treatment with Tradamixina.
Fig. 3
Fig. 3
Rigiscan Results Pre and Post Treatment with Tradamixina.
Fig. 4
Fig. 4
Rigiscan Results Pre and Post Treatment with Tadalafil 5mg Daily.
Fig. 5
Fig. 5
IIEF Score Pre and Post Treatment with Tradamixina.
Fig. 6
Fig. 6
IIEF Score Pre and Post Treatment with Tadalafil 5mg Daily.
Fig. 7
Fig. 7
IIEF Total Score Ttradamixina vs Tadalafil mg 5 mg Daily.
Fig. 8
Fig. 8
Area 1 and Area 3 Scores Pre and Post Treatment Ttradamixina vs Tadalafil 5mg Daily.

Similar articles

Cited by

References

    1. Morley JE. Testosterone and behavior. Clin Geriatr Med. 2003;19:605–616. doi: 10.1016/S0749-0690(02)00106-4. - DOI - PubMed
    1. Matsumoto AM. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol Med Sci. 2002;57:M76–M99. doi: 10.1093/gerona/57.2.M76. - DOI - PubMed
    1. Traish AM, Miner MM, Morgentaler A, Zitzmann M. Testosterone deficiency. Am J Med. 2011;124(7):578–87. doi: 10.1016/j.amjmed.2010.12.027. - DOI - PubMed
    1. Alexander B. Disorders of sexual desire: diagnosis and treatment of decreased libido. Am Fam Physician. 1993;47:832–838. - PubMed
    1. Mohr BA, Guay AT, O’Donnell AB, McKinlay A. Normal, bound and non bound testosterone levels in normally ageing men: results from the Massachusetts. JB. 2005. - PubMed

Publication types

MeSH terms